Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-04-08 Purchase |
2025-04-10 08:39 am |
MBX Biosciences Inc. | MBX | Pescovitz Ora H. Director |
7,693 | $5.89 | $45,312 | 24,329 (Direct) |
View |
2025-02-14 Purchase |
2025-02-19 5:56 pm |
MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner |
190,672 | $10.6 | $2,020,756 | 747,887 (Indirect) |
View |
2025-02-14 Purchase |
2025-02-19 5:52 pm |
MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
190,672 | $10.6 | $2,020,756 | 747,887 (Indirect) |
View |
2025-02-04 Purchase |
2025-02-05 4:17 pm |
MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO |
50,000 | $10.69 | $534,500 | 1,172,674 (Indirect Direct) |
View |
2024-09-16 Purchase |
2024-09-17 8:28 pm |
MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner |
500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) |
View |
2024-09-16 Purchase |
2024-09-17 8:26 pm |
MBX Biosciences Inc. | MBX | BASKETT FOREST 10% Owner |
500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) |
View |
2024-09-16 Purchase |
2024-09-17 8:24 pm |
MBX Biosciences Inc. | MBX | Behbahani Ali 10% Owner |
500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) |
View |
2024-09-16 Purchase |
2024-09-17 8:23 pm |
MBX Biosciences Inc. | MBX | Chang Carmen 10% Owner |
500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) |
View |
2024-09-16 Purchase |
2024-09-17 8:21 pm |
MBX Biosciences Inc. | MBX | Florence Anthony A. Jr. 10% Owner |
500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) |
View |
2024-09-16 Purchase |
2024-09-17 8:20 pm |
MBX Biosciences Inc. | MBX | Makhzoumi Mohamad 10% Owner |
500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) |
View |
2024-09-16 Purchase |
2024-09-17 8:18 pm |
MBX Biosciences Inc. | MBX | Walker Paul Edward 10% Owner |
500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) |
View |
2024-09-16 Purchase |
2024-09-17 8:17 pm |
MBX Biosciences Inc. | MBX | Yang Rick 10% Owner |
500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) |
View |
2024-09-16 Purchase |
2024-09-17 8:14 pm |
MBX Biosciences Inc. | MBX | SANDELL SCOTT D 10% Owner |
500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) |
View |
2024-09-16 Purchase |
2024-09-17 8:13 pm |
MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
750,000 | $16 | $12,000,000 | 653,787 (Indirect) |
View |
2024-09-16 Purchase |
2024-09-17 8:12 pm |
MBX Biosciences Inc. | MBX | New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner |
500,000 | $16 | $8,000,000 | 3,614,486 (Direct) |
View |
2024-09-16 Purchase |
2024-09-17 8:11 pm |
MBX Biosciences Inc. | MBX | Frazier Life Sciences X L.P. FHMLS X L.P. FHMLS X L.L.C. Topper James N 10% Owner |
625,000 | $16 | $10,000,000 | 4,552,774 (Direct) |
View |
2024-09-16 Purchase |
2024-09-17 8:09 pm |
MBX Biosciences Inc. | MBX | Heron Patrick J Director 10% Owner |
625,000 | $16 | $10,000,000 | 4,552,774 (Indirect) |
View |
2024-09-16 Purchase |
2024-09-17 8:05 pm |
MBX Biosciences Inc. | MBX | Aynechi Tiba Director |
750,000 | $16 | $12,000,000 | 2,136,335 (Indirect) |
View |
2024-09-16 Purchase |
2024-09-17 8:05 pm |
MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner |
750,000 | $16 | $12,000,000 | 653,787 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-07 Option Award |
2025-04-09 08:27 am |
N/A 2035-04-07 |
MBX Biosciences Inc. | MBX | Hoerter Steven L. Director |
32,000 | $0 | 32,000 (Direct) |
View |
2025-02-03 Option Award |
2025-02-05 4:17 pm |
N/A 2035-02-03 |
MBX Biosciences Inc. | MBX | Azoulay Salomon Chief Medical Officer |
90,000 | $0 | 90,000 (Direct) |
View |
2025-02-03 Option Award |
2025-02-05 4:17 pm |
N/A 2035-02-03 |
MBX Biosciences Inc. | MBX | Bartram Richard Chief Financial Officer |
95,000 | $0 | 95,000 (Direct) |
View |
2025-02-03 Option Award |
2025-02-05 4:17 pm |
N/A 2035-02-03 |
MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO |
243,000 | $0 | 1,172,674 (Direct) |
View |
2024-09-16 Conversion |
2024-09-17 8:28 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner |
40,557,180 | $0 | 3,614,486 (Indirect) |
View |
2024-09-16 Conversion |
2024-09-17 8:26 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | BASKETT FOREST 10% Owner |
40,557,180 | $0 | 3,614,486 (Indirect) |
View |
2024-09-16 Conversion |
2024-09-17 8:24 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Behbahani Ali 10% Owner |
40,557,180 | $0 | 3,614,486 (Indirect) |
View |
2024-09-16 Conversion |
2024-09-17 8:23 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Chang Carmen 10% Owner |
40,557,180 | $0 | 3,614,486 (Indirect) |
View |
2024-09-16 Conversion |
2024-09-17 8:21 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Florence Anthony A. Jr. 10% Owner |
40,557,180 | $0 | 3,614,486 (Indirect) |
View |
2024-09-16 Conversion |
2024-09-17 8:20 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Makhzoumi Mohamad 10% Owner |
40,557,180 | $0 | 3,614,486 (Indirect) |
View |
2024-09-16 Conversion |
2024-09-17 8:18 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Walker Paul Edward 10% Owner |
40,557,180 | $0 | 3,614,486 (Indirect) |
View |
2024-09-16 Conversion |
2024-09-17 8:17 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Yang Rick 10% Owner |
40,557,180 | $0 | 3,614,486 (Indirect) |
View |
2024-09-16 Conversion |
2024-09-17 8:14 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | SANDELL SCOTT D 10% Owner |
40,557,180 | $0 | 3,614,486 (Indirect) |
View |
2024-09-16 Conversion |
2024-09-17 8:13 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
39,876,501 | $0 | 653,787 (Indirect) |
View |
2024-09-16 Conversion |
2024-09-17 8:12 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner |
40,557,180 | $0 | 3,614,486 (Direct) |
View |
2024-09-16 Conversion |
2024-09-17 8:11 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Frazier Life Sciences X L.P. FHMLS X L.P. FHMLS X L.L.C. Topper James N 10% Owner |
51,147,891 | $0 | 4,552,774 (Direct) |
View |
2024-09-16 Conversion |
2024-09-17 8:11 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | CORNELIUS JAMES M Director |
1,329,343 | $0 | 102,082 (Direct) |
View |
2024-09-16 Conversion |
2024-09-17 8:09 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Heron Patrick J Director 10% Owner |
51,147,891 | $0 | 4,552,774 (Indirect) |
View |
2024-09-16 Conversion |
2024-09-17 8:07 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO |
5,205,750 | $0 | 879,674 (Direct) |
View |
2024-09-16 Conversion |
2024-09-17 8:05 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Aynechi Tiba Director |
18,053,001 | $0 | 2,136,335 (Indirect) |
View |
2024-09-16 Conversion |
2024-09-17 8:05 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner |
39,876,501 | $0 | 653,787 (Indirect) |
View |
2024-09-16 Conversion |
2024-09-17 7:15 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% Owner |
23,311,156 | $0 | 1,790,122 (Direct) |
View |
2024-09-12 Option Award |
2024-09-13 5:19 pm |
N/A 2034-09-11 |
MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner |
15,963 | $0 | 15,963 (Direct) |
View |
2024-09-12 Option Award |
2024-09-13 5:17 pm |
N/A 2034-09-11 |
MBX Biosciences Inc. | MBX | Ryder Steven Director |
15,963 | $0 | 15,963 (Direct) |
View |
2024-09-12 Option Award |
2024-09-13 5:13 pm |
N/A 2034-09-11 |
MBX Biosciences Inc. | MBX | Bartram Richard Chief Financial Officer |
42,578 | $0 | 42,578 (Direct) |
View |
2024-09-12 Option Award |
2024-09-13 5:11 pm |
N/A 2034-09-11 |
MBX Biosciences Inc. | MBX | Azoulay Salomon Chief Medical Officer |
45,011 | $0 | 45,011 (Direct) |
View |
2024-09-12 Option Award |
2024-09-13 5:11 pm |
N/A 2034-09-11 |
MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner |
15,963 | $0 | 15,963 (Direct) |
View |
2024-09-12 Option Award |
2024-09-13 5:06 pm |
N/A 2034-09-11 |
MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO |
120,436 | $0 | 120,436 (Direct) |
View |
2024-09-12 Option Award |
2024-09-13 5:04 pm |
N/A 2034-09-11 |
MBX Biosciences Inc. | MBX | Aynechi Tiba Director |
15,963 | $0 | 15,963 (Direct) |
View |
2024-09-12 Option Award |
2024-09-13 5:04 pm |
N/A 2034-09-11 |
MBX Biosciences Inc. | MBX | Heron Patrick J Director 10% Owner |
15,963 | $0 | 15,963 (Direct) |
View |
2024-09-12 Option Award |
2024-09-13 5:02 pm |
N/A 2034-09-11 |
MBX Biosciences Inc. | MBX | CORNELIUS JAMES M Director |
15,963 | $0 | 15,963 (Direct) |
View |
2024-09-12 Option Award |
2024-09-13 5:00 pm |
N/A 2034-09-11 |
MBX Biosciences Inc. | MBX | Pescovitz Ora H. Director |
15,963 | $0 | 15,963 (Direct) |
View |
Ownership |
2024-09-12 7:52 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% Owner |
0 | $0 | 1,790,122 (Direct) |
View |
Ownership |
2024-09-12 7:38 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Yang Rick 10% Owner |
0 | $0 | 3,114,486 (Indirect) |
View |
Ownership |
2024-09-12 7:36 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Walker Paul Edward 10% Owner |
0 | $0 | 3,114,486 (Indirect) |
View |
Ownership |
2024-09-12 7:34 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO |
0 | $0 | 1,910,632 (Direct) |
View |